Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
OTC Markets
ETFs
Canadian ETFs
US ETFs
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Fusion Pharmaceuticals Inc.
FUSN
Healthcare
Biotechnology
Fusion Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing alpha therapeutics for curing cancer. It...
develops Targeted Alpha Therapies (TAT) together with its proprietary Fast-Clear linker technology. The firm's lead product candidate comprises FPI-1434, a monotherapy for the treatment of a variety of cancers; FPI-1966, for the treatment of head and neck and bladder cancers; and FPI-2059 among others.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:FUSN)
New Post
View:
Posts & Comments
Threaded Posts
(50)
•••
Tarbaby
X
Post by
Tarbaby
on Dec 23, 2022 11:44am
Good News?
Someone must have some good news in their cancer trials. Lets hope its a start to a great 2023.
(50)
•••
Tarbaby
X
Post by
Tarbaby
on Oct 25, 2022 9:28pm
Insider Selling
Why is the CEO selling shares consistently over more than a year... If he doesnt believe in the success of this company he should not be the CEO. Or do they just Gift themselves far too many shares
...more
Cedar Clinical Research, by Numinus, the top enrolling clinical research site for MindMed's Phase 2B study evaluating MM-120
posted Jun 06, 2023 9:00am by
Numinus Wellness Inc.
-
|
"We're excited to support MindMed in their clinical trial work, by evaluating new important treatments and protocols to address mental health disorders...The fact that our Draper research clinic is the top enrolling site for the study underscores the quality of our clinical research capabilities and recruiting efforts ...read more
(50)
•••
Tarbaby
X
Comment by
Tarbaby
on Sep 14, 2022 3:01pm
RE:RE:Price drop
Moving Up Nicely.. Finally starting clinical trials. Thats great news. Lets hope the treatment works well. Its definitely the future in cancer treatments..like Smart Bombs that find the tumors but
...more
(50)
•••
Tarbaby
X
Comment by
Tarbaby
on May 10, 2022 9:35am
RE:Price drop
Wow...money is being spent at a rate of $100 million per year with no assurance of future income. That cant go on for too long. What is the projected timeline for income from cancer treatments
...more
(50)
•••
Tarbaby
X
Post by
Tarbaby
on Apr 14, 2022 10:43am
Price drop
Why is the price dropping so fast. I think the company should publish more updates on their ongoing activities. Investors need some news ...good or bad.
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video
{{moreVideoText}}
Next Video >
Featured News Links
Will 2023 be a Record-Breaking Year for Precious Metal Prices? – Experts insight available here
Full Circle Lithium Makes Significant Advancing in their Lithium Recycling Demo Plant Buildout and Related Technology
Rapid Expansion of Dehydratech into USA Cannabis Markets Leads to Rapid Revenue Growth